Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Eduarda Bertolazzi Teixeira
Observed name:
M.E. Teixeira
Institution:
Pontifícia Universidade Católica do Paraná
Observed institutions:
Pontifícia Universidade Católica do Paraná,
Centro Hospitalar Lisboa Norte,
Hospital de Santa Maria,
Hospital CUF Descobertas
ORCID:
0009-0009-1350-2564
Observed ORCID:
0009-0009-1350-2564
OpenAlex ID:
A5057826585
Application of CDK4/6 Inhibitors in Head and Neck Squamous Cell Carcinoma: What we Have Learned from Breast Cancer
2026
·
Maria Eduarda Bertolazzi Teixeira
, Ana Clara Sanitá de Camargo
, et al.
·
Brazilian Journal of Oncology
The action of Palbociclib on the Cell Cycle of Head and Neck Squamous Cell Carcinoma: A Systematic Review
2025
·
Maria Eduarda Bertolazzi Teixeira
, João Pedro Fabrini da Silva
, et al.
·
Brazilian Journal of Oncology
PDF
1212P IMpower010: Characterisation of patients (pts) with stage II-IIIA PD-L1 TC≥50% NSCLC who were disease-free at 5 years (5yDF) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after resection and adjuvant (adj) chemotherapy (chemo)
2024
·
E. Felip
, E. Vallieres
, et al.
·
Annals of Oncology
123P IMpower010: Exploratory overall survival (OS) with adjuvant atezolizumab (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression
2022
·
A. Rittmeyer
, E. Felip
, et al.
·
Immuno-Oncology Technology
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type